Home > About GAMMAGARD LIQUID > GAMMAGARD LIQUID SubQ

GAMMAGARD LIQUID for
Subcutaneous (SubQ) Administration

Sustained Protection Against Infection1,2

SubQ administration of GAMMAGARD LIQUID treatment has been shown to be effective in a clinical study.

  • Annual rate of less than 0.1 validated acute serious bacterial infections per subject-yeara
  • 3 cases of serious validated bacterial pneumonia; none required hospitalization to treat the infection
  • No hospitalizations secondary to acute serious bacterial infections over the course of the clinical study

aThe upper 99% confidence limit of 0.133 is substantially lower than the minimal goal of achieving a rate of <1 bacterial infection per subject-year.


Demonstrated Tolerability in the Clinical Study1

In the GAMMAGARD LIQUID clinical study for SubQ administration, there was demonstrated tolerability.

Please see below for Detailed Important Risk Information.

of infusions were completed without reducing the infusion rate or stopping the infusion due to
side effects, or tolerability issues.b

bThe safety of GAMMAGARD LIQUID in SC infusions was evaluated in 47 subjects during all SC treatment periods.


Sometimes additives can be an issue for certain people. GAMMAGARD LIQUID treatment is formulated with1:

  • Added Sugars1
  • Added Sodium1
  • Added Preservatives1
  • Added Proline1

  • Stabilized and buffered with glycine for those patients in whom these additives may be a concern1
  • The packaging is not made with natural rubber latex1

GAMMAGARD LIQUID Brochure

To learn more about PI and treatment with GAMMAGARD LIQUID treatment, both IV and SubQ, you can download the brochure from our Additional Resources page.

References: 1. GAMMAGARD LIQUID [Immune Globulin Infusion (Human)] 10% [package insert]. Westlake Village, CA: Baxter Healthcare Corporation. 2. Wasserman RL, Melamed I, Kobrynski L, et al. Efficacy, safety, and pharmacokinetics of 10% liquid immune globulin preparation (GAMMAGARD LIQUID, 10%) administered subcutaneously in subjects with primary immunodeficiency disease. J Clin Immunol. 2011;31:323-331.

    

  • Sign up to get access to experienced Patient and Nurse Advocates, insurance and financial support, useful tools, and more.
    Enroll Now
  • 
  • Ask an Advocate Questions about PI or PI treatments? Our trained Patient and Nurse Advocates can help, and asking your question is easy with our Ask An Advocate feature.
    Start Getting Answers
  • 
  • SubQ Patient
    Training Kit
    Get a training DVD, infusion mat, and
    step-by-step guide with in-depth information to help you get started on subcutaneous (SubQ) administration of GAMMAGARD LIQUID treatment.
    Learn How

You are now leaving GAMMAGARD.com

Shire is not responsible for the privacy policy, the content or the accuracy of any web site accessed through a link on the GAMMAGARD.com site. A link to other web sites does not constitute an endorsement of Shire of the linked site, its products or services.

The browser window or tab for GAMMAGARD.com will remain open underneath the new browser window or tab. To return to GAMMAGARD.com at any time, close this tab or window.

Return to
GAMMAGARD.com
Continue

Terms and Conditions

Patient instructions

  1. By using this coupon, you are certifying that:
  2. 1) You meet the eligibility criteria and have read and agree to the terms and conditions of this manufacturer coupon program;
  3. 2) You will not, at any time, submit any costs for the product dispensed pursuant to this coupon to any government healthcare program for reimbursement;
  4. 3) You are permitting your personal information, including name, address, phone number, email address, and information related to health insurance and treatment, to be shared with Shire and companies working with Shire for the purpose of administering this program; and
  5. 4) You will notify your health insurance provider or other third-party payer of the use of this coupon if required to do so.
  6. If your insurance situation changes it is your responsibility to notify Shire's MyIgCoPayCard program.
  7. For questions about this program, patients and caregivers can call MyIgSource at (855) 250-5111.

Pharmacy instructions

  1. By submitting a claim for reimbursement pursuant to this manufacturer coupon program, the Pharmacy represents and warrants that:
  2. 1) It has dispensed GAMMAGARD LIQUID treatment to an eligible patient and in accordance with the terms and conditions of this program and the accompanying prescription;
  3. 2) Its participation in this program is consistent with all applicable laws and any obligations, including its contract with the applicable payer;
  4. 3) If the patient's insurance situation changes, it will notify Shire immediately by contacting the MyIgCoPayCard program;
  5. 4) It will report coupon assistance received to payers if so required; and
  6. 5) The entire benefit amount received will go to eligible expenses and it will not retain any portion of the benefit as payment to it for administration or ineligible expenses.
  7. For questions regarding processing, claim transmission, patient eligibility, or other issues, pharmacists can call the MyIgCoPayCard program directly at (855) 217-1615.